Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Lara S. Sullivan, M.D.$261M
Market Cap • 23/04/20242018
(há 6 anos)
2021
(3 years ago)
NASDAQ
Listagem
Boston
Sede • Massachusetts75
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
PYXSSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.